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Abstract
The quantified self community brings together enthusiasts who are using technological devices to monitor their
health and social media to share their personal data with others online. In light of the growing popularity of this
movement, self-trackers are challenging the health-care system by raising important questions about data
ownership and risk-taking. As we enter a new era of consumer genomics, a significant number of quantified self
(QS) individuals are now interested in the monitoring of their microbiome and performing personal interventions.
In this paper, we discuss the scientific validity of experiments involving serial observations of a single individual as
opposed to randomized clinical trials. We look at self-tracking from an ethical standpoint by questioning the risks
and assessing the potential benefits for personalized medicine in general and for microbiome research in particular.
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Background
With the advent and recent acceptance of self-tracking,
a large number of individuals are now relying on techno-
logical tools and wearable sensors to monitor and
analyze their daily activities as a way of improving per-
formance, productivity, or any other factors involved in
personal well-being [1]. Nowhere is this so-called quan-
tified self (QS) movement more active and important
than in medicine [2–4], with online blogs [5, 6], and
self-help books [7] of people claiming to have cured spe-
cific diseases on their own using self-tracking and data
logging. With annual conferences, workshops, online
forums, and specialized journals, this large community
of people primarily motivated by health issues is challen-
ging the medical profession and pushing for a change.
Although it is currently impossible to monitor the
microbiome at home, some crowdfunded biotech start-
ups [8, 9] are offering a paying service to analyze one’s
microbiome as part of a larger citizen science movement
[10]. Using data visualization tools, one could then find
out what types of people have a microbiome like theirs
and understand how their microbiome changes over time.
With this also comes the possibility of laypersons doing
experiments and personal interventions on their micro-
biota to alleviate a specific disease or health condition
[11]. Sure enough, individualized microbiome analyses will
be of growing interest in the years to come [12]. In this
paper, we will discuss the pros and cons of personal exper-
imentations, performed either by amateurs or scientists,
from a scientific and ethical standpoint, questioning the




Self-tracking involves collecting all sorts of data which
can be measured about the self, including biological,
psychological, physical, behavioral, or environmental in-
formation [1], as a way to optimize a specific lifestyle
and resolve a personal problem or disease, such as sleep
disorder, mood swings, sexual dysfunction, diabetes,
obesity, and irritable bowel syndrome. To do so, self-
trackers are using digital tools, wearable devices, con-
nected gadgets, and computer apps to collect, monitor,
analyze, visualize, interpret, and share their data online
with the general public and other members of the
community [13].
The jury is still out about the real benefits (efficiency/
applicability) of self-tracking in medicine, despite its
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increasing popularity [14, 15]. On the other hand, self-
experimentation has a long tradition in medical research,
with several breakthrough discoveries attributed directly
to this mode of private practice [16]. Here, we posit that
self-trackers are a new breed of self-experimenters,
whether amateur or professionals, a category of individ-
uals motivated by their own health, who are conducting
experimental studies on themselves. In self-tracking, the
user, practitioner, and the beneficiary of the study are
the same person. In self-experimentation, the practi-
tioner is the user, while the beneficiaries can be anyone
else. Yet, the process of measuring, analyzing, and un-
derstanding one’s personal data is slowly being replaced
by group data collected by individual self-trackers driven
by similar goals and using standardized protocols to
serve the community as a whole [17]. This methodo-
logical shift from private self-tracking to the pushed,
communal, imposed, and exploited types of self-tracking
[18] has important implications. Namely, as more and
more of these community-based projects will be under-
taken, an exponential amount of information will be
made available, raising concerns about data ownership
[19], integration, and quality.
QS individuals indirectly contributed to the emergence
of biocitizenship [20], a movement dedicated to empower
individuals to take care of their own health [21, 22]. Self-
trackers are also part of the larger field of digitally engaged
patients [23] advocating self-monitoring and self-care as
an alternative approach to medicine. As such, they repre-
sent a driving force for the promotion of predictive, pre-
ventive, personalized, and participatory (P4) medicine, as
envisioned by Leroy Hood to transform the existing
health-care system [24, 25]. In spite of its promising
future, serious concerns have been raised about the
scientific robustness and ethical validity of quantified
self-tracking, either performed by a single individual
or by a group of individuals.
Is self-tracking scientifically valid?
As with any study based on a single individual, self-
tracking suffers from severe shortcomings: scientific
validity and generalization. Besides these obvious flaws,
objections to self-research also question the difficulty of
controlling for environmental and hereditary variables,
lack of models to help in the conduct of self-
experimentation, and the well-know placebo effect [1].
Because self-tracking studies are not randomized or
blinded in traditional ways, also comes the problem of
publication in peer-reviewed journals. But above all, it is
the personal involvement and motivations of the experi-
menter, which for some, make the research less objective
and more open to questionable interpretation.
Modern self-trackers are not unaware of the problems
associated with studies based on a single subject, and
they are constantly trying to find new ways, individually or
collectively, to improve their methods and further scien-
tific acceptance of their results. The fact is that many per-
sons involved in self-tracking are bona fide researchers,
with a background in experimental science. Some are ac-
tually using grant money and lab resources to perform
long-term vertical studies [26], while others are doing this
as a hobby, outside of their main research area [27], even
claiming that, in specific cases, self-experimentation was
far better than their mainstream research [28].
Advocates and practitioners of self-tracking and self-
experimentation argue that advantages of individual-
based studies are numerous. For one, it is far cheaper
than conventional research using clinical trials. It is also
easier to do and more flexible, thus allowing to study a
wider range of problems by measuring many things at
once [28]. Additional benefits of self-tracking are about
velocity of question asking and the multiplicity of experi-
ment iterating [1]. As the research questions are
prompted by the users in a bottom-up fashion, data can
be gathered much more rapidly, thus accelerating the
whole experimental process. In the spirit of citizen sci-
ence, self-tracking data are available online for every-
body to use, which engages the whole community to
take part in the process of scientific discovery, either by
combining data, comparing data or re-analyzing the data
of a particular experiment [3]. And by combining per-
sonal data with data collected from a group of partici-
pants motivated by a similar problem, the information
begins to resemble more traditional scientific experi-
ments and clinical trials [29].
In spite of this, the fundamental question remains. In
the absence of standardized research protocols and ana-
lytical procedures for studying private behavior, can the
credibility of self-experimentation as science consist in
the generality and replicability of the method [30], or in
other words, can there be a science of n = 1? In the con-
text of microbiome research, where n =me, this question
takes a whole different meaning, since “me” is more than
just human cells. Self-tracking the microbiome is not
about tracking single individuals, it is about studying an
entire ecosystem of microbes representing N different
species and M different genes. Typically, as N and M are
respectively in the hundreds and thousands, someone in-
terested in the monitoring of the gut microbiome can
collect a massive amount of metagenomic data, large
enough to test specific hypotheses with great statistical
significance, even more so, if one were also to collect
data from other body sites, such as the vaginal micro-
biome, the oral microbiome, or the skin microbiome.
Is self-tracking ethically acceptable?
In addition to its scientific soundness, the ethical validity
of self-experimentation has been debated at length [31].
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Sure enough, self-tracking is convenient: getting in-
formed consent is a given, requiring neither conversa-
tion with the subjects nor complex paperwork; the
subject/investigator is well informed and understands
the research protocol, compliance is not a problem, and
cash inducements are not required [32]. Taken at face
value, the moral advantages of self-experimentation are
many, with maximum identification of the subjects, un-
derstanding, and spontaneity. However, these theoretical
advantages are not enough to make self-experimentation
ethically acceptable [33]. For one, people who self-
experiment with devices, get testing that is available
direct-to-consumer or participate in crowdfunded re-
search all have to pay for these devices and tests. This
creates a gap between the people who can afford to do
this type of self-experimentation and people who cannot
afford it. There is then the potential to exacerbate exist-
ing health disparities. In addition, the analysis of one’s
personal data by a third party also raises the problem of
dual-use research and innovation [34] and its precau-
tionary aspects, namely, when data sharing can lead to
both beneficial and harmful uses [35].
Of course, no one can stop individuals to perform any
type of self-experiments on themselves, even dangerous
ones. It is when other participants are recruited for
group self-experimentations and other exploited types of
self-tracking [18] that ethical problems may arise. Davis
[32] proposes a framework for evaluation of such pro-
jects using three criteria: the good faith argument, the
golden rule argument, and the risk argument. To the ex-
tent that self-experimentation is neither necessary nor
sufficient to justify enrolling non-investigators, he con-
cludes that there is no ethical reason to encourage group
self-experimentation [32]. Similarly, there is a significant
gap in ethical oversight with regard to bottom-up,
participant-led health research [36]. According to some,
Institutional Review Boards (IRBs) are structured for the
old world of scientific inquiry, whereas citizen science
blurs the lines between the research subject and the re-
searchers [37]; in self-tracking, the two are the same per-
son. One interesting proposal yet to be explored is that
of crowdsourcing ethics review [38], also called IRB 2.0.
A code of conduct for data sharing in biocitizen project is
also warranted [39], whereas concerns over security and
privacy [40] are something that self-tracking individuals
have so far ignored altogether.
Discussion
The self-tracking movement has been slow to pick up
with microbiome research, except for some individuals
interested in the restoration of their ancestral gut micro-
biome [41], and all those trying fecal transplants at
home without medical supervision [42]. As far as we
know, Larry Smarr’s self-experimentation was the first
published study that has looked at the relationship be-
tween gut microbiome and Crohn’s disease [11]. In a
more recent self-tracking study, two researchers from
Harvard and MIT have been using themselves as re-
search subjects in a yearlong monitoring project of their
gut (and oral) microbiome on a daily timescale [43]. Ob-
viously, any given individual interested in replicating
such experiments must have access to the technology it-
self or the funds necessary to purchase the technology
or testing service, which is not easy if you are not
already a scientist. However, looking at the range of
companies currently offering to sequence your genome
or microbiome (e.g., American Gut Project, uBiome,
my.microbes, DIYgenomics, Genomera), the number of
self-tracking projects making use of commercial kits to
analyze microbiome is likely to grow in the years to come.
As sequencing costs will go down, more and more people
are going to perform self-experiments, and new citizen
science projects conducted in collaboration with academic
labs will gain in popularity. The accumulation of observa-
tions for single individuals may then provide insights
about the dynamics of the microbiome in groups of indi-
viduals. Surely, this type of collaborative research provides
an interesting and promising complementary approach to
top-down, hypothesis-driven, and researcher-led research.
Conclusion
Self-trackers are a special breed of self-experimenters,
following in the footsteps of many others in the history
of medicine [44]. They can perform experiments that
clinical trials would never do, for lack of time, money, or
interest. They can do so, more rapidly, extensively, and
repeatedly. Despite the controversy about non-medically
trained people taking full responsibility of their own
bodies and making behavioral changes to achieve per-
sonal goals, this will not stop [11]. This trend is here is
to stay and unlikely to be reversed. Instead of rejecting it
on scientific grounds, we should address it by developing
standard protocols for the framing of participant-led re-
search involving self-tracking. Instead of refusing it on
ethical basis, we should think about novel ways of asses-
sing informed consent, anonymity, and transparency. A
growing number of concerned individuals are demand-
ing for socially robust citizen science [45], and self-
trackers are a political force at the forefront of this
movement. For sure, self-trackers have numbers on their
side. By combining (n = 1) + (n = 1) + (n = 1) at infinitum,
it is extremely likely that one of those n will make an
important discovery. Namely, the first microbiome cock-
tail for treating Clostridium difficile infections was devel-
oped based on a study involving n = 2 subjects [46].
What’s the next breakthrough going to be? A cure for
Crohn’s disease, psoriasis, depression, or any other
microbiome-related condition, the end of obesity, or a
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revolutionary treatment for cancer patients? How many
self-trackers will contribute to such discoveries? Not un-
like Barry Marshall who received a Nobel Prize in 2005
for discovering the cause of gastritis by ingesting
Helicobacter pylori, Jessica Richman, cofounder of
uBiome, recently asked at a conference [47] whether a citi-
zen scientist could win a Nobel Prize? Only time will tell.
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